6 Followers on Owler

Aldeyra Therapeutics

develops and commercializes medicines for the treatment of retinal inflammation, lymphoproliferative disease and cancer... Read more
OverviewCompetitorsAcquisitionsFundingNews & Insights

Aldeyra Therapeutics

develops and commercializes medicines for the treatment of retinal inflammation, lymphoproliferative disease and cancer... Read more
Aldeyra Therapeutics President & CEO: Todd C. Brady

President & CEO

Todd C. Brady

CEO Approval Rating

90/100

2004

PublicIndependent CompanyNASDAQALDX

Pharmaceuticals & Biotechnology
Pharmaceuticals
2834 NAICS listing

Annual Revenue
$ < 1M
Employees
10
Funding
$22M
Acquisitions
1

News

Regulatory
Nov 19, 2024
Zacks
ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap

Aldeyra Therapeutics Competitors

1Acceleron
2Immune Design
3Evoke Pharma
4bluebird bio
5Sangamo
6Inovio
7Kite Pharma
8ANI
9Orchard Therapeutics
10CRISPR
See 26+ competitors

Trending Companies